Screener
TG Therapeutics TGTX Net debt
Discontinued — last reported Q2 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from TG Therapeutics’s reported figures.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
FAQ
- What is TG Therapeutics's net debt?
- TG Therapeutics (TGTX) reported net debt of $271.87M in Q2 2026.
- How has TG Therapeutics's net debt changed year-over-year?
- TG Therapeutics's net debt increased by 118.2% year-over-year, from $124.59M to $271.87M.
- What is the long-term trend for TG Therapeutics's net debt?
- Over 5 years (2020 to 2025), TG Therapeutics's net debt has grown at a -19.3% compound annual growth rate (CAGR), from -$511.46M to $174.56M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about TG Therapeutics's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude